According to IMARC Group’s latest report, titled “Virus Filtration Market: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” the global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027. Report Metric Historical: 2016-2021 Base Year: 2021 Forecast Year: 2022-2027 We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Virus filtration refers to a robust and effective virus clearance technology used in the manufacturing of biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within the pores of the membrane from biotech and plasma processes. It provides a critical defense mechanism against the introduction of adventitious viruses into a different class of medicines. Request Free Sample Report: https://www.imarcgroup.com/virus-filtration-market/requestsample Market Trends Biological therapeutic products are generally produced using mammalian cell lines or human plasma, which increases the risk of contamination. This, in confluence with the rising need for therapeutic products on account of the growing prevalence of chronic diseases, represents one of the key factors driving the demand for virus filtration solutions across the globe. Apart from this, governing agencies of numerous countries are implementing stringent regulations to ensure the virological safety of biological therapeutics. This is encouraging pharmaceutical manufacturers to integrate virus filtration methods to evaluate and mitigate the risks of virus contamination. Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/virus-filtration-market List of Key Companies Covered in this Market Report: Asahi Kasei Medical Co. Ltd. Charles River Laboratories, Inc (NYSE: CRL) Clean Cells Danaher Corporation (NYSE: DHR) Merck KGaA (ETR: MRK) Sartorius AG (ETR: SRT) Thermo Fisher Scientific Inc.(NYSE: TMO) The report has segmented the market on the basis of product, application, end use and geography. Breakup by Product: Consumables Kits and Reagents Others Instruments Filtration Systems Chromatography Systems Services Breakup by Application: Biologicals Vaccines and Therapeutics Blood and Blood Products Cellular and Gene Therapy Products Others Medical Devices Water Purification Air Purification Others Breakup by End Use: Biopharmaceutical and Biotechnology Companies Contract Research Organizations Academic Institutes and Research Laboratories Others Breakup by Geography: North America (U.S. & Canada) Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others) Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others) Latin America (Brazil, Mexico) Middle East & Africa Key highlights of the report: Market Performance (2016-2021) Market Outlook (2022- 2027) Porter’s Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization. About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact US IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800 Follow us on Twitter: https://twitter.com/ImarcServices
Virus Filtration Market Report 2022-27: Size, Scope, Growth, Trends and Forecast
According to IMARC Group’s latest report, titled “Virus Filtration Market: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” the global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027. Report Metric Historical: 2016-2021 Base Year: 2021 Forecast Year: 2022-2027 We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Virus filtration refers to a robust and effective virus clearance technology used in the manufacturing of biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within the pores of the membrane from biotech and plasma processes. It provides a critical defense mechanism against the introduction of adventitious viruses into a different class of medicines. Request Free Sample Report: https://www.imarcgroup.com/virus-filtration-market/requestsample Market Trends Biological therapeutic products are generally produced using mammalian cell lines or human plasma, which increases the risk of contamination. This, in confluence with the rising need for therapeutic products on account of the growing prevalence of chronic diseases, represents one of the key factors driving the demand for virus filtration solutions across the globe. Apart from this, governing agencies of numerous countries are implementing stringent regulations to ensure the virological safety of biological therapeutics. This is encouraging pharmaceutical manufacturers to integrate virus filtration methods to evaluate and mitigate the risks of virus contamination. Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/virus-filtration-market List of Key Companies Covered in this Market Report: Asahi Kasei Medical Co. Ltd. Charles River Laboratories, Inc (NYSE: CRL) Clean Cells Danaher Corporation (NYSE: DHR) Merck KGaA (ETR: MRK) Sartorius AG (ETR: SRT) Thermo Fisher Scientific Inc.(NYSE: TMO) The report has segmented the market on the basis of product, application, end use and geography. Breakup by Product: Consumables Kits and Reagents Others Instruments Filtration Systems Chromatography Systems Services Breakup by Application: Biologicals Vaccines and Therapeutics Blood and Blood Products Cellular and Gene Therapy Products Others Medical Devices Water Purification Air Purification Others Breakup by End Use: Biopharmaceutical and Biotechnology Companies Contract Research Organizations Academic Institutes and Research Laboratories Others Breakup by Geography: North America (U.S. & Canada) Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others) Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others) Latin America (Brazil, Mexico) Middle East & Africa Key highlights of the report: Market Performance (2016-2021) Market Outlook (2022- 2027) Porter’s Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization. About Us IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact US IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800 Follow us on Twitter: https://twitter.com/ImarcServices